Hamid Safraz A, Graetz Elena, Schneider Eric B, Schwartz Jennifer S, Ghiassi Saber, Gibbs Karen E
Department of Surgery, Yale School of Medicine, New Haven, CT, United States; Yale National Clinician Scholars Program, New Haven, CT, United States.
Department of Surgery, Yale School of Medicine, New Haven, CT, United States; Yale Surgery Health Services and Outcomes Research Center, New Haven, CT, United States.
J Gastrointest Surg. 2025 Aug;29(8):102107. doi: 10.1016/j.gassur.2025.102107. Epub 2025 Jun 2.
A subset of patients undergoing metabolic and bariatric surgery (MBS) for obesity treatment develop gastroparesis. It remains unclear how gastroparesis influences MBS outcomes.
This study queried the 2016-2022 Nationwide Readmissions Database for patients aged ≥18 years with obesity who underwent sleeve gastrectomy or Roux-en-Y gastric bypass (RYGB). The primary outcomes were 30-day readmission, 30-day reoperation, length of stay (LOS), and discharge disposition. The secondary outcome was procedure type. This study investigated the unadjusted (using t tests, Kruskal-Wallis tests, and chi-square tests) and adjusted (using logistic regression) associations between gastroparesis status and outcomes.
Of 1,120,048 patients, 5738 (0.51%) had gastroparesis. Patients with gastroparesis were proportionally more likely to undergo RYGB than those without gastroparesis (65.6% vs 30.3%, respectively; P <.001). In addition, compared to patients without gastroparesis, those with gastroparesis had higher readmission rates (3.4% vs 7.7%, respectively; P <.001) and reoperation rates (1.0% vs 2.3%, respectively; P <.001) and were more likely to have longer LOS (median days: 1.0 vs 2.0, respectively; P <.001) and require home health services (1.8% vs 3.1%, respectively; P <.001). After adjusting for sociodemographic and clinical factors, patients with gastroparesis were 63.0% more likely to experience readmission (adjusted odds ratio [aOR], 1.64 [95% CI, 1.36-1.96]), 58.0% more likely to undergo reoperation (aOR, 1.58 [95% CI, 1.12-2.28]), and 75.4% more likely to stay >72 h in the hospital (aOR, 1.75 [95% CI, 1.46-2.11]).
MBS patients with gastroparesis more frequently undergo RYGB than the MBS population without gastroparesis. Patients with gastroparesis experience higher readmission and reoperation rates and are more likely to have a longer LOS. MBS teams should consider counseling patients about the risk of these postoperative events.
一部分接受代谢和减重手术(MBS)以治疗肥胖症的患者会发生胃轻瘫。胃轻瘫如何影响MBS的治疗效果仍不清楚。
本研究查询了2016 - 2022年全国再入院数据库中年龄≥18岁且接受袖状胃切除术或Roux - en - Y胃旁路术(RYGB)的肥胖患者。主要结局包括30天再入院、30天再次手术、住院时间(LOS)和出院处置。次要结局是手术类型。本研究调查了胃轻瘫状态与结局之间的未调整关联(使用t检验、Kruskal - Wallis检验和卡方检验)和调整关联(使用逻辑回归)。
在1,120,048例患者中,5738例(0.51%)患有胃轻瘫。与无胃轻瘫的患者相比,胃轻瘫患者接受RYGB的比例更高(分别为65.6%和30.3%;P <.001)。此外,与无胃轻瘫的患者相比,胃轻瘫患者的再入院率更高(分别为3.4%和7.7%;P <.001)、再次手术率更高(分别为1.0%和2.3%;P <.001),住院时间更长的可能性更大(中位数天数:分别为1.0天和2.0天;P <.001),且更需要家庭健康服务(分别为1.8%和3.1%;P <.001)。在对社会人口统计学和临床因素进行调整后,胃轻瘫患者再入院的可能性增加63.0%(调整后的优势比[aOR],1.64 [95%置信区间,1.36 - 1.96]),再次手术的可能性增加58.0%(aOR,1.58 [95%置信区间,1.12 - 2.28]),住院超过72小时的可能性增加75.4%(aOR,1.75 [95%置信区间,1.46 - 2.11])。
与无胃轻瘫的MBS患者相比,患有胃轻瘫的MBS患者更常接受RYGB。胃轻瘫患者的再入院和再次手术率更高,住院时间更长的可能性更大。MBS团队应考虑向患者咨询这些术后事件的风险。